1. Home
  2. INBX vs GCTS Comparison

INBX vs GCTS Comparison

Compare INBX & GCTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INBX
  • GCTS
  • Stock Information
  • Founded
  • INBX 2010
  • GCTS 1998
  • Country
  • INBX United States
  • GCTS United States
  • Employees
  • INBX N/A
  • GCTS N/A
  • Industry
  • INBX Biotechnology: Pharmaceutical Preparations
  • GCTS Blank Checks
  • Sector
  • INBX Health Care
  • GCTS Finance
  • Exchange
  • INBX Nasdaq
  • GCTS Nasdaq
  • Market Cap
  • INBX 222.5M
  • GCTS 243.2M
  • IPO Year
  • INBX 2020
  • GCTS N/A
  • Fundamental
  • Price
  • INBX $16.21
  • GCTS $2.83
  • Analyst Decision
  • INBX Hold
  • GCTS Strong Buy
  • Analyst Count
  • INBX 1
  • GCTS 1
  • Target Price
  • INBX N/A
  • GCTS $8.00
  • AVG Volume (30 Days)
  • INBX 47.7K
  • GCTS 132.2K
  • Earning Date
  • INBX 08-13-2024
  • GCTS 11-14-2024
  • Dividend Yield
  • INBX N/A
  • GCTS N/A
  • EPS Growth
  • INBX N/A
  • GCTS N/A
  • EPS
  • INBX 118.83
  • GCTS N/A
  • Revenue
  • INBX $1,687,000.00
  • GCTS $13,398,000.00
  • Revenue This Year
  • INBX N/A
  • GCTS N/A
  • Revenue Next Year
  • INBX N/A
  • GCTS $571.35
  • P/E Ratio
  • INBX $0.14
  • GCTS N/A
  • Revenue Growth
  • INBX 24.26
  • GCTS N/A
  • 52 Week Low
  • INBX $10.80
  • GCTS $2.26
  • 52 Week High
  • INBX $18.95
  • GCTS $56.00
  • Technical
  • Relative Strength Index (RSI)
  • INBX 56.54
  • GCTS 56.55
  • Support Level
  • INBX $15.24
  • GCTS $2.61
  • Resistance Level
  • INBX $16.79
  • GCTS $2.76
  • Average True Range (ATR)
  • INBX 0.59
  • GCTS 0.18
  • MACD
  • INBX 0.02
  • GCTS 0.04
  • Stochastic Oscillator
  • INBX 62.56
  • GCTS 98.28

About INBX Inhibrx Inc.

Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.

About GCTS GCT Semiconductor Holding Inc. Common Stock

GCT Semiconductor Holding Inc. is a designer and supplier of 5G and 4G LTE semiconductor solutions. It enabled fast and reliable 4G LTE connectivity to numerous commercial devices such as CPEs, mobile hotspots, routers, M2M applications and smartphones, etc. The system-on-chip solutions integrate radio frequency, baseband modem and digital signal processing functions, therefore offering complete 4G and 5G platform solutions with small form factors, low power consumption, high performance, high reliability, and cost-effectiveness.

Share on Social Networks: